The AHA in comments today to the Centers for Medicare & Medicaid Services on its interim final rule for its COVID-19 vaccine mandate for hospitals and other participants in the Medicare and Medicaid program urged the agency to be flexible as it begins enforcement. Such flexibility and discretion in CMS’ enforcement, AHA said, will help mitigate uncertainty as court challenges to the mandate persist, while enabling hospitals and health systems to navigate workforce challenges without disrupting patient care. AHA also asked CMS to provide clarification for the agency’s complex, broad-sweeping interpretive guidance, including developing a means for hospitals to quickly get answers to their questions on compliance with the interim final rule.

Related News Articles

Headline
The Centers for Disease Control and Prevention yesterday recommended children age 5-11 receive a booster dose five months after completing the Pfizer COVID-19…
Headline
U.S. residents can order online eight more free at-home tests for COVID-19, the White House announced yesterday. People who have difficulty accessing the…
Headline
The Food and Drug Administration today authorized a single Pfizer COVID-19 booster dose for children aged 5-11 who completed the Pfizer vaccine primary series…
Headline
The Food and Drug Administration yesterday approved using Olumiant (baricitinib) to treat COVID-19 in hospitalized adults requiring supplemental oxygen,…
Headline
The Food and Drug Administration last week extended to 24 months the shelf life for certain lots of refrigerated bamlanivimab. The combination monoclonal…
Headline
The Centers for Medicare & Medicaid Services Friday released updated guidance on COVID-19 vaccination coverage and reimbursement to help Medicaid, Children…